RE: Market reaction28 Jun 2019 09:46
As expected positive update this morning. However, the trial did not include a placebo group. Hence, the initial phase 3 trial failure not totally reversed. This extension looked at safety and efficacy of the drug which proved to be a success. Will be rolled out to some and not everyone with this disease so expect further tie-in news. GLA